Experienced in Long QT Syndrome

Veronique Michaud

Ecole Polytechnique Fédérale De Lausanne, Station 12, 
Lausanne, VD, CH 
Experienced in Long QT Syndrome
Ecole Polytechnique Fédérale De Lausanne, Station 12, 
Lausanne, VD, CH 
OverviewLocationsClinical Research

Overview

Veronique Michaud practices in Lausanne, Switzerland. Ms. Michaud is rated as an Experienced expert by MediFind in the treatment of Long QT Syndrome. Her top areas of expertise are Long QT Syndrome, Type 2 Diabetes (T2D), Serotonin Syndrome, Bone Marrow Transplant, and Colonoscopy.

Her clinical research consists of co-authoring 82 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Long QT Syndrome.

Gender
Female

Locations

Ecole Polytechnique Fédérale De Lausanne, Station 12, Lausanne, VD 1015, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Retrospective Study Assessing the Value of Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting
Retrospective Study Assessing the Value of Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting
Enrollment Status: Unknown
Publish Date: September 02, 2022
Intervention Type: Other
Effects of Type 2 Diabetes on CYP450s Activities; Intersubject Variability in Drug Metabolism.
Effects of Type 2 Diabetes on CYP450s Activities; Intersubject Variability in Drug Metabolism.
Enrollment Status: Completed
Publish Date: July 23, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

82 Total Publications

Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 09, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Michaud's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile